Ketamine harm rose across several data sources.
Reported nonmedical use, poison-center cases, and overdose deaths with ketamine all rose over overlapping periods.
See what the data shows and what we still need to learn.
Here is what studies found. We also list the questions that still need answers.
Each card links to its source.
Reported nonmedical use, poison-center cases, and overdose deaths with ketamine all rose over overlapping periods.
More than 80% also involved fentanyl, meth, or cocaine.
Reports rose from 2019 to 2023, both in number and as a share of cases with a known reason.
The cited data covers accidental and undetermined-intent overdose deaths.
Researchers still need to answer these questions.
How many overdose deaths had ketamine and prior suicidal thoughts or attempts?
How often is ketamine found in suicide deaths across all methods?
How many deaths are tested for ketamine each year?
Where did ketamine-related harms happen: street, home, or clinic?
Do people using ketamine report more suicidal thoughts after accounting for depression?
What happens when people start, continue, or stop ketamine treatment?
What do death certificates say about ketamine and intent?
How many suicides are tested for ketamine at all?
What's actually in the tusi being sold in the US?
Analyze public NSDUH data on ketamine use and suicide-related thoughts, plans, and attempts. Publish the code and results.
Update a public ketamine data tracker with each CDC release.
Publish a guide for journalists on ketamine found in the body versus involved in a death.
Work with medical examiners to count every death with ketamine in it, not just overdoses. We're starting with Miami-Dade.
We plan to fund studies that account for testing changes, link records, and study youth ketamine use.